Form 8-K - Current report:
SEC Accession No. 0000950170-23-012492
Filing Date
2023-04-12
Accepted
2023-04-12 08:22:34
Documents
14
Period of Report
2023-04-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cue-20230411.htm   iXBRL 8-K 83287
2 EX-10.1 cue-ex10_1.htm EX-10 35135
  Complete submission text file 0000950170-23-012492.txt   261433

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cue-20230411_def.xml EX-101.DEF 13504
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cue-20230411.xsd EX-101.SCH 2917
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cue-20230411_pre.xml EX-101.PRE 13511
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cue-20230411_lab.xml EX-101.LAB 16077
8 EXTRACTED XBRL INSTANCE DOCUMENT cue-20230411_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 23814680
SIC: 2834 Pharmaceutical Preparations